Yi, H., Qiu, M., Yuan, L., Luo, Q., Pan, W., Zhou, S., . . . Yang, D. (2020). Bcl‐2/Bcl‐xl inhibitor APG‐1252‐M1 is a promising therapeutic strategy for gastric carcinoma. Cancer Med.
Citação norma ChicagoYi, Hanjie, Miao‐Zhen Qiu, Luping Yuan, Qiuyun Luo, Wentao Pan, Suna Zhou, Lin Zhang, Xianglei Yan, and Da‐Jun Yang. "Bcl‐2/Bcl‐xl Inhibitor APG‐1252‐M1 Is a Promising Therapeutic Strategy for Gastric Carcinoma." Cancer Med 2020.
ציטוט MLAYi, Hanjie, et al. "Bcl‐2/Bcl‐xl Inhibitor APG‐1252‐M1 Is a Promising Therapeutic Strategy for Gastric Carcinoma." Cancer Med 2020.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.